Clinical Trials Browser

Phase 1/2 × Breast Neoplasms, Male × poly(I).poly(c12,U) × Clear all

NCT01355393 2020-02-10

Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer

Phase 1/2 Completed

Breast Neoplasms, Breast Neoplasms, Male